Tango Therapeutics Inc (TNGX) Peer Comparison

$25.28

$-0.19 (-0.75%)

As on 27-Aug-2026 16:00EDT

Market cap

$4,026 Mln

Revenue (TTM)

$54 Mln

P/E Ratio

--

P/B Ratio

3.9

Div. Yield

0 %

Edit

	Tango Therapeutics Inc (TNGX)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Market cap ($ Mln)	4,026	16,614	17,326	13,400	12,305
Revenue ($ Mln)	54	1,054	2,782	2,436	670
Net Profit ($ Mln)	-123.72	755.85	491.50	860.62	-319.95
Net Margin (%)	-229.92	71.69	17.67	35.33	-47.79
RoE (%)	-18.05	--	110.09	42.98	-71.14
Price to Earnings	--	19.38	36.49	17.01	--
Price-To-Book	3.87	10.05	39.43	7.27	26.44

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Tango Therapeutics Inc (TNGX)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Operating Revenue	53.81	1,054.37	2,782.29	2,435.92	669.50
Cost of Revenue	1.50	103.47	1,982.07	85.67	19.14
Gross Profit	60.10	588.53	760.62	2,236.43	829.45
Operating Expenses	189.22	841.45	216.81	1,378.74	895.93
Operating Profit (EBIT)	-136.35	109.45	583.40	971.51	-226.44
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-123.78	101.11	598.92	1,035.47	-252.08
Provision for Tax	-0.06	-654.74	107.42	174.84	20.05
Profit after Tax (Net Income)	-123.72	755.85	491.50	860.62	-319.95
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Tango Therapeutics Inc (TNGX)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Shareholder's Funds	1,024.53	1,435.90	433.86	1,843.76	465.53
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Non-Current Liabilities	29.05	384.48	187.89	288.55	1,362.63
Current Liabilities	20.30	464.70	1,435.43	361.93	283.35
Total Liabilities	398.69	1,302.02	1,975.47	2,844.42	1,385.30

Assets ($ Mln)

	Tango Therapeutics Inc (TNGX)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Non-Current Assets	42.21	895.24	1,006.90	1,243.41	440.60
Current Assets	1,031.67	1,389.84	1,050.29	1,250.82	1,671.41
Total Assets	398.69	1,302.02	1,975.47	2,844.42	1,385.30
Total Debt*	31.99	449.89	120.10	165.93	864.07
Net Current Assets	0.00	0.00	-385.14	888.90	1,388.07

Cashflow ($ Mln)

	Tango Therapeutics Inc (TNGX)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Cash From Operating Activities	-138.89	51.77	713.22	884.27	179.55
Cash Flow from Investing Activities	-40.87	-8.15	-31.14	350.44	-129.29
Cash from Financing Activities	222.50	34.89	-860.39	-969.59	74.01
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Tango Therapeutics Inc (TNGX)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
ROCE (%)	-33.00	-30.01	53.56	32.82	-0.17
ROE (%)	-18.05	163.18	110.09	42.98	-71.14
ROA (%)	-10.38	26.53	15.64	29.32	-16.12
EBIT Margin (%)	-127.19	5.73	21.13	31.04	-0.77
Net Margin (%)	-229.92	71.69	17.67	35.33	-47.79
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Tango Therapeutics Inc (TNGX)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Revenue Growth (%)	121.47	114.85	24.67	9.23	12.22
EBIT Growth (%)	52.93	136.39	18.70	-3.99	93.17
Net Profit Growth (%)	15.01	378.76	17.50	42.89	-115.58
EPS Growth (%)	34.01	353.27	26.84	50.42	-73.87
Book Value Growth (%)	459.93	816.12	164.02	-0.70	-13.57

Valuation Ratios

	Tango Therapeutics Inc (TNGX)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Price / Earnings	-10.13	-59.76	36.06	15.79	-2,869.63
Price / Book Value	2.97	-80.42	35.44	5.72	10.04
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	-7.25	-121.54	28.08	12.44	25.04
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Tango Therapeutics Inc (TNGX)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debt to Equity	0.00	0.00	0.00	0.00	1.77
Short term debt to equity ratio	0.00	0.05	0.00	0.00	0.09
Current Ratio	50.82	2.99	0.73	3.46	5.90
Quick Ratio	50.82	2.32	0.73	3.38	5.90
Interest Coverage	--	1.62	--	--	-1.72

Operating Efficiency Ratios

	Tango Therapeutics Inc (TNGX)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debtors to sales (%)	0.00	21.25	15.88	13.74	1.28
Asset Turnover	0.05	0.37	0.89	0.83	0.34
Receivable days	--	85.52	50.42	43.48	1.50
Inventory Days	--	1,056.70	--	96.17	--
Payable days	222.82	331.01	6.26	147.97	221.81
Cash Conversion Cycle	--	811.21	--	-8.32	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly